Description
Release form
Capsules.
Indications
acute and recovery periods of severe traumatic brain injury and ischemic stroke, recovery period of hemorrhagic stroke, occurring with focal hemisphere symptoms or symptoms of damage to the brain stem
psycho-organic syndrome against the background of degenerative and involutional cerebral circulatory disorders (impaired mental function, memory, confusion, disorientation, decreased motivation, ciency and the ability to focus), including dementia and encephalopathy.
senile pseudomelancholy.
Contraindications
Hypersensitivity, pregnancy, breastfeeding.
Special instructions
If you experience nausea after taking the drug, you should reduce the dose. Cerepro does not affect the speed of psychomotor reactions.
Composition
One capsule contains:
as the active substance 400 mg glycerylphosphorylcholine hydrate (choline alfoscerate)
excipients:
glycerol (glycyrin),
purified water.
Capsule shell:
medical gelatin,
glycerol (glycerin),
methyl parahydroxybenzoate (methyl paraben),
propyl parahydroxybenzoate (propyl paraben),
dye sorbitol iron oxide, redbit srdp, drd
Dosage and administration of
In acute conditions: intramuscularly or intravenously (slowly) at 1.0 g (1 ampoule) per day for 10-15 days, then go on to take capsules orally at 0.8 g (2 capsules) in the morning and 0.4 g (1 capsule) during the day for 6 months.
In chronic conditions: inside, 0.4 g (1 capsule) 3 times a day, preferably before meals. The duration of treatment is 3-6 months.
Side effects
Allergic reactions, nausea (due to dopaminergic activation).
Drug Interactions
Not detected.
Overdose
Symptoms: dyspeptic disorders.
Treatment: gastric lavage, intake of activated carbon, symptomatic therapy.
Storage conditions
In a dry, dark place and out of the reach of children at a temperature of 25 ° C.
Expiration
2 years.
Deystvuyuschee substances
Choline alfostserat
Conditions of supply of pharmacies
Prescription
Form of Treatment
kapsul
